Enanta’s Phase II Challenge Data Position A Second Potential RSV Therapy

 
• By Joseph Haas
  
RSV illus
Enanta is advancing two antivirals to treat RSV infections • Source: Shutterstock

More from Clinical Trials

More from R&D